SERVICES

Transforming Knowledge into Insight

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions.

Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.

Award-Winning Equity Research

For seven consecutive years, Leerink Swann has been recognized for its healthcare research. Every year since 2001, Institutional Investor has named Leerink Swann a Best of the Boutiques in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major, and Pharmaceuticals/Specialty. In 2006 and 2007, Institutional Investor added Health Care Technology & Distribution to that list of accolades for Leerink Swann.

Universe of Coverage

Leerink Swann analysts and researchers maintain regular coverage of a wide variety of leading healthcare companies.